QuantumPharm Inc. (HKG: 2228)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.950
-0.090 (-2.23%)
Nov 22, 2024, 10:21 AM HKT

QuantumPharm Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Revenue
197.08174.42133.3562.8
Revenue Growth (YoY)
213.83%30.80%112.35%-
Cost of Revenue
104.8107.5760.127.42
Gross Profit
92.2966.8573.2535.38
Selling, General & Admin
541.67414.93295.59177.88
Research & Development
430.18442.8315.36201.76
Other Operating Expenses
-79.94-72.125.28-16.42
Operating Expenses
891.92785.61616.22363.22
Operating Income
-799.63-718.77-542.97-327.84
Interest Expense
-9.46-9.58-5.75-3.58
Interest & Investment Income
88.39102.6950.4814.06
Earnings From Equity Investments
-2.97-1.96-0.24-4.5
Currency Exchange Gain (Loss)
5.47-40.375.919.43
EBT Excluding Unusual Items
-718.2-667.98-492.56-312.43
Gain (Loss) on Sale of Investments
38.16-4.38-9.6210.36
Other Unusual Items
-1,844-1,234-936.43-1,835
Pretax Income
-2,524-1,906-1,439-2,137
Earnings From Continuing Operations
-2,524-1,906-1,439-2,137
Minority Interest in Earnings
-14.82-8.060.110.04
Net Income
-2,538-1,914-1,439-2,137
Net Income to Common
-2,538-1,914-1,439-2,137
Shares Outstanding (Basic)
607484484482
Shares Outstanding (Diluted)
607484484482
Shares Change (YoY)
25.77%-0.35%-
EPS (Basic)
-4.18-3.96-2.97-4.43
EPS (Diluted)
-4.19-3.96-2.97-4.43
Free Cash Flow
-681-691.36-622.52-414.32
Free Cash Flow Per Share
-1.12-1.43-1.29-0.86
Gross Margin
46.83%38.32%54.93%56.34%
Operating Margin
-405.73%-412.09%-407.17%-522.05%
Profit Margin
-1287.98%-1097.57%-1078.72%-3403.38%
Free Cash Flow Margin
-345.54%-396.37%-466.82%-659.76%
EBITDA
-717.4-647.96-495-315.45
D&A For EBITDA
82.2370.8147.9712.4
EBIT
-799.63-718.77-542.97-327.84
Source: S&P Capital IQ. Standard template. Financial Sources.